NDC 71863-216 – Increlex

Mecasermin 40 mg/4mL · Injection · Subcutaneous

Human Prescription Drug

Product NDC71863-216

Product details

Brand name
Increlex
Generic name
Mecasermin
Labeler
Eton Pharmaceuticals, Inc.
Dosage form
Injection
Route
Subcutaneous
Marketing category
BLA · BLA021839
Marketed since
April 16, 2025
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Increlex →

Package NDC codes (1)

Package NDCDescriptionSince
71863-216-041 VIAL, MULTI-DOSE in 1 CARTON (71863-216-04) / 4 mL in 1 VIAL, MULTI-DOSEApr 16, 2025

Other Increlex products